MétaCan
Menu
Back to cohort
Record W2588786146 · doi:10.1093/neuonc/now188.137

P08.04 Antitumor effects of medroxyprogesterone on glial tumor growth in vitro and in vivo and an unexpected contribution of PI3Kinase on anti-invasive effects of steroids

2016· article· en· W2588786146 on OpenAlexaff
Meriç A. Altinoz, Fatih Han Bölükbaşı, Joséphine Nalbantoglu, Rolando F. Del Maestro, İlhan Elmacı

Bibliographic record

VenueNeuro-Oncology · 2016
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer therapeutics and mechanisms
Canadian institutionsMontreal Neurological Institute and Hospital
Fundersnot available
KeywordsMedroxyprogesteroneIn vivoMedicineIn vitroCancer researchPharmacologyMedroxyprogesterone acetateOncologyInternal medicineChemistryBiologyHormoneBiochemistry

Abstract

fetched live from OpenAlex

INTRODUCTION: Among the cytosolic sex steroid receptors, progesterone receptor is the one which most significantly associated with the tumor grade in glial neoplasms. Progesterone gradually increases from the first until the last day of pregnancy and reaches 200-fold of its prepartum luteal concentrations. Glial tumors manifest more during the first trimester yet their incidence become lesser at the last trimester of gestation. Additionally; in opposite to meningiomas, women gender, being everparous and progesterone-containing hormone replacement therapy (HRT) reduces risk of glial tumors. Medroxyprogesterone acetate (MPA) is a widely used 17-OH-progesterone for contraception and HRT and strongly activates progesterone receptor and to a lesser extent, glucocorticoid receptor (GR). Antiedema agents like dexamethasone (Dex) bind to the GR, which were also shown to reduce glial tumor invasiveness. MATERIALS AND METHODS: In this investigation, we studied in vitro antitumor effects of MPA on human glial tumor cell lines (U87 and U251) and the contribution of PI3-Kinase pathway on the anti-invasive efficacies of MPA and Dex. We also studied in vivo efficacy of MPA on C6 glioma implanted into Wistar rat brains. RESULTS: At low doses, (3,25 to 16,3 μM) MPA slightly and insignificantly induced growth of U87 and U251 human glioblastoma cells in monolayer cultures. At doses higher than 52 μM, cell numbers drastically reduced and few cells survived at 104 μM. In 3D-spheroid cultures maintained in semisolid type-I collagen, MPA and Dex dose-dependently reduced tumor invasion even at low dosages. Unexpectedly, PI3-Kinase inhibitors LY294002 and wortmannin at low dosages hindered anti-invasive effects of both MPA and Dex. PI3-Kinase pathway is mostly pro-tumorigenic, yet few studies also demonstrated that this pathway may also transmit antitumor signals. To the best of our knowledge, this is the first study which showed that benefits of antiedema steroids in glial tumors may occur via PI3Kinase. In Wistar rats inoculated with C6 glioma, 50 mg/kg/day MPA reduced tumor volume by about 50 percent in 3 weeks. CONCLUSIONS: Considering the high safety of MPA and also that blood progesterone levels up to 160 μM are tolerable in human, these current investigations warrant further study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.017

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.251
Teacher spread0.246 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicCancer therapeutics and mechanismsFrench-language works237,207